Galena Biopharma EV to EBITDA (TTM)
Galena Biopharma EV to EBITDA (TTM) Chart
Galena Biopharma Historical EV to EBITDA (TTM) Data
|Data for this Date Range|
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
About EV / EBITDA
EV/EBITDA is the enterprise value of a company divided by its earnings before interest, taxes, depreciation and amortization. (EV/EBITDA)
EV/EBITDA answers the question "What is a company being valued per each dollar of EBITDA?" A high (low) EV/EBITDA mean the company is potentially overvalued (undervalued).
EV/Financial Metrics are often used by analysts to quickly look at a company's valuation multiples. All things being equal, the lower this ratio is, the better.
Other similar metrics include :
EV/Revenues: How much is each dollar of revenues worth to investors?
EV/EBIT : Or each dollar of EBIT?
EV/Free Cash Flow : Or each dollar of FCF?
For more information on evaluating valuation multiples similar to this, please see our original white paper research : Making Sense Of Valuation Multiples.
GALE EV to EBITDA (TTM) Benchmarks
GALE EV to EBITDA (TTM) Excel Add-In Codes
- Metric Code: ev_ebitda
- Latest data point: =YCP("GALE", "ev_ebitda")
- Last 5 data points: =YCS("GALE", "ev_ebitda", -4)
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Globe Newswire 04/27 07:05 ET
Globe Newswire 04/26 07:05 ET
MT Newswires 04/19 12:07 ET
Accesswire 04/07 09:30 ET
Accesswire 04/04 09:00 ET
MT Newswires 03/30 10:24 ET
Accesswire 03/30 10:20 ET
MT Newswires 03/30 08:53 ET
Yahoo 03/29 12:42 ET